Targetable fibroblast phenotypes and EMT malignant cell states cooperate to promote tumor progression in esophageal adenocarcinoma
Robert Walker(Royal Surrey NHS Foundation Trust), Tim Underwood(Southampton General Hospital)
Cited by 2
Related Papers
Cancer‐associated fibroblasts predict poor outcome and promote periostin‐dependent invasion in oesophageal adenocarcinoma
|The Journal of Pathology|2014|182
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
|The Lancet. Gastroenterology & hepatology|2019|64
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
|Gut|2019|27